BTIG’s healthcare analyst Hartaj Singh came out with a research note on Keryx Biopharmaceuticals (NASDAQ:KERX), after the company reported its fourth-quarter financial results and provided a corporate update. The analyst …
J.P.
In a research report issued Friday, BTIG analyst Hartaj Singh reiterated a Neutral rating on Keryx Biopharmaceuticals (NASDAQ:KERX), after the company released its full …
Brean Capital’s healthcare analyst Jonathan Aschoff weighed in today with a few insights on Keryx Biopharmaceuticals (NASDAQ:KERX), as the company’s shares have reacted negatively to …
Cowen’s healthcare analyst Boris Peaker weighed in today with a few insights on Keryx Biopharmaceuticals (NASDAQ:KERX), following yesterday’s meeting with the company’s management team. The …
Cowen analyst Boris Peaker was out today with a research note on Keryx Biopharma (NASDAQ:KERX), following Friday’s release of IMS scripts data for Aurixya. The analyst rates …
Cowen analyst Boris Peaker weighed in today with his thoughts on Keryx Biopharmaceuticals (NASDAQ:KERX), following the news that the FDA approved Rockwell Medical’s (NASDAQ:RMTI) Triferic …
In a research report issued this morning, Brean Capital analyst Jonathan Aschoff reiterated a Buy rating on Keryx Biopharmaceuticals (NASDAQ:KERX) with a $26 …
